医学
中止
抗生素
重症监护医学
中性粒细胞减少症
发热性中性粒细胞减少症
内科学
化疗
微生物学
生物
作者
Jana Dickter,Cathy Logan,Randy Taplitz
标识
DOI:10.1097/qco.0000000000000932
摘要
Purpose of review Our aim is to review recent literature on antibiotic use in patients with neutropenia. Recent findings Prophylactic antibiotics are associated with risks and have limited mortality benefit. While early antibiotic use in febrile neutropenia (FN) is critical, early de-escalation or discontinuation may be safe in many patients. Summary With an increasing understanding of potential risks and benefits of use and improved risk assessment, paradigms of antibiotic use in neutropenic patients are changing.
科研通智能强力驱动
Strongly Powered by AbleSci AI